Conference Coverage

Dr. Eve Espey: Some good news in her 2019 contraceptive update


 

EXPERT ANALYSIS FROM ACOG 2019

Additional future directions

One technology in development is a longer-acting injectable, such as a 6- or 9-month Depot-type shot.

Biodegradable implants also are in development. “What a cool idea – it just disappears in your arm, no need to remove it,” Dr. Espey said, adding that nonsurgical permanent sterilization is another possible advance, which would be “a holy grail.”

As for male contraception?

“I’ve been saying for about 25 years that in 5 years we’ll have a male contraceptive, so I’m not going to say it anymore with any kind of time frame, but it’s possible,” she said.

Dr. Espey reported having no financial disclosures.

Pages

Recommended Reading

Trump proposes cutting Planned Parenthood funds
MDedge Endocrinology
Transgender men need counseling on contraceptive and reproductive choices
MDedge Endocrinology
FDA approves first mobile app for contraceptive use
MDedge Endocrinology
Hormonal contraceptive use linked to leukemia risk in offspring
MDedge Endocrinology
Ulipristal reduces bleeding with contraceptive implant
MDedge Endocrinology
Trump administration rule erodes ACA contraceptive mandate
MDedge Endocrinology
Levonorgestrel implant right after delivery does not affect breastfeeding, infant growth
MDedge Endocrinology
FDA expands Essure’s postmarketing surveillance study
MDedge Endocrinology
2019 Update: Contraceptives and unintended pregnancy rates
MDedge Endocrinology
Addressing the sexual and reproductive health needs of trans and gender nonconforming patients
MDedge Endocrinology